MicroRNA‐26a is a novel regulator of vascular smooth muscle cell function

Journal of Cellular Physiology - Tập 226 Số 4 - Trang 1035-1043 - 2011
Nicholas J. Leeper1, Azad Raiesdana2, Yoko Kojima2, Hyung J. Chun2, Junya Azuma2, Lars Mäegdefessel2, Ramendra K. Kundu2, Thomas Quertermous2, Philip S. Tsao2, Joshua M. Spin2
1Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305, USA,
2Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California

Tóm tắt

AbstractAberrant smooth muscle cell (SMC) plasticity has been implicated in a variety of vascular disorders including atherosclerosis, restenosis, and abdominal aortic aneurysm (AAA) formation. While the pathways governing this process remain unclear, epigenetic regulation by specific microRNAs (miRNAs) has been demonstrated in SMCs. We hypothesized that additional miRNAs might play an important role in determining vascular SMC phenotype. Microarray analysis of miRNAs was performed on human aortic SMCs undergoing phenotypic switching in response to serum withdrawal, and identified 31 significantly regulated entities. We chose the highly conserved candidate miRNA‐26a for additional studies. Inhibition of miRNA‐26a accelerated SMC differentiation, and also promoted apoptosis, while inhibiting proliferation and migration. Overexpression of miRNA‐26a blunted differentiation. As a potential mechanism, we investigated whether miRNA‐26a influences TGF‐β‐pathway signaling. Dual‐luciferase reporter assays demonstrated enhanced SMAD signaling with miRNA‐26a inhibition, and the opposite effect with miRNA‐26a overexpression in transfected human cells. Furthermore, inhibition of miRNA‐26a increased gene expression of SMAD‐1 and SMAD‐4, while overexpression inhibited SMAD‐1. MicroRNA‐26a was also found to be downregulated in two mouse models of AAA formation (2.5‐ to 3.8‐fold decrease, P < 0.02) in which enhanced switching from contractile to synthetic phenotype occurs. In summary, miRNA‐26a promotes vascular SMC proliferation while inhibiting cellular differentiation and apoptosis, and alters TGF‐β pathway signaling. MicroRNA‐26a represents an important new regulator of SMC biology and a potential therapeutic target in AAA disease. J. Cell. Physiol. 226: 1035–1043, 2011. © 2010 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1016/j.jtcvs.2009.07.075

10.2174/156652408786733739

10.3791/1280

10.1172/JCI38864

10.1586/14779072.4.6.789

Chun HJ, 2008, Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis, J Clin Invest, 118, 3343

10.4161/cc.8.1.7292

10.1074/jbc.M808788200

10.1161/ATVBAHA.107.159327

10.1016/S0021-9150(03)00201-6

10.1007/BF02623563

10.1093/cvr/cvn151

10.1101/gr.082701.108

10.1016/j.semcancer.2008.01.008

10.1161/01.CIR.99.1.96

10.1016/j.jvs.2004.06.018

10.1186/gb-2007-8-9-r183

10.1038/nprot.2008.211

10.1101/gad.1777409

10.1253/circj.CJ-09-0059

10.1359/JBMR.051001

10.1161/CIRCRESAHA.106.141986

10.1002/jcp.21577

10.1016/j.cell.2009.04.021

10.1038/ng1536

10.1073/pnas.0804438105

10.1161/CIRCRESAHA.108.185363

10.1359/jbmr.071011

10.1161/01.RES.0000266448.30370.a0

10.1152/physrev.1995.75.3.487

10.1083/jcb.102.2.343

10.1161/01.CIR.99.15.2019

10.4161/cc.8.4.7599

10.1016/j.jvs.2005.02.027

SpinJM HsuM AzumaJ TsaoPS.2009. Transcriptional profiling and network analysis of the murine angiotensin II‐induced abdominal aortic aneurysm model; 2009; Omni Shoreham Hotel Washington DC.e112.

10.1097/00019501-199710000-00005

10.1073/pnas.091062498

10.1093/cvr/cvn156

10.1016/j.jvs.2006.01.004

10.1074/jbc.M709614200

10.1152/ajpendo.00385.2009

10.1186/gm85

Thông tin
Thông tin xuất bản

Journal of Cellular Physiology

Tập 226 Số 4

1035-1043

Thông tin tác giả